Profil Financier
Patrick Soon-Shiong occupe actuellement le rang #292 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $11.7 B (+$387 sur 24h).
Medical doctor Patrick Soon-Shiong invented the cancer drug Abraxane. It became a blockbuster thanks to its efficacy against pancreatic cancer.
He sold his drug companies Abraxis in 2010 and American Pharmaceutical Partners in 2008 for a combined $9.1 billion.
He took his cancer drug maker NantKwest public in 2015 and his biotech startup NantHealth public in 2016.
He owns NantWorks, a network of health startups, and has stakes in media firm Tribune Publishing and the Los Angeles Lakers.
He bought the Los Angeles Times and San Diego Tribune for $500 million in June 2018.
In May 2020, Soon-Shiong's ImmunityBio was selected for the federal government's "Operation Warp Speed" to help quickly develop a Covid-19 vaccine.
Soon-Shiong graduated from high school at age 16 and became a doctor at 23.
Soon-Shiong was born in South Africa to Chinese immigrants.